Good Glycemic Control Is Positively Associated with the Levels of Serum Albumin and Postprandial C-Peptide after Long-Term Continuous Subcutaneous Insulin Infusion Treatment in Patients with Type 2 Diabetes

被引：0
|
作者：
Choi, Soo-Bong
Noh, Yun-Hee
Lee, Jun-Ho
Lee, Ju-Han
Kim, Seonguk
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2216-PO
引用
收藏
页码：A590 / A590
页数：1
相关论文
共 50 条
  • [41] Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
    Senn, Jon-Duri
    Fischli, Stefan
    Slahor, Lea
    Schelbert, Susanne
    Henzen, Christoph
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03)
  • [42] Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes
    Scrimgeour, Laura
    Cobry, Erin
    McFann, Kim
    Burdick, Pat
    Weimer, Casey
    Slover, Robert
    Chase, H. Peter
    DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (05) : 421 - 428
  • [43] Improved Pancreatic Beta Cell Function in Type 2 Diabetes During Long-Term Continuous Subcutaneous Insulin Infusion Therapy
    Choi, Soo B.
    An, Hyun Ju
    Kim, Kyung Jin
    Noh, Yun H.
    DIABETES, 2012, 61 : A225 - A225
  • [44] Serum irisin concentrations were increased after transient continuous subcutaneous insulin infusion in type 2 diabetes mellitus patients
    Li, Liang
    Rampersad, Sharvan
    Wang, Xingchun
    Cheng, Xiaoyun
    Qu, Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 113 : 44 - 47
  • [45] Noninferiority Effects on Glycemic Control and β-Cell Function Improvement in Newly Diagnosed Type 2 Diabetes Patients: Basal Insulin Monotherapy Versus Continuous Subcutaneous Insulin Infusion Treatment
    Zeng, Longyi
    Lu, Hongyun
    Deng, Hongrong
    Mu, Panwei
    Li, Xiaofeng
    Wang, Manman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (01) : 35 - 42
  • [46] Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial
    Yuan, Guoyue
    Hu, Hao
    Wang, Su
    Yang, Qichao
    Yu, Shuqin
    Sun, Wenjun
    Qian, Weiyun
    Mao, Caoming
    Zhou, Libin
    Chen, Dezhi
    Wang, Zhaoling
    Gong, Qin
    Wang, Dong
    ENDOCRINE JOURNAL, 2015, 62 (09) : 817 - 834
  • [47] A Randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control
    DeVries, JH
    Snoek, FJ
    Kostense, PJ
    Masurel, N
    Heine, RJ
    DIABETES CARE, 2002, 25 (11) : 2074 - 2080
  • [48] Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system
    Moreno-Fernandez, Jesus
    Lopez, Luz Maria
    Gomez, Francisco Javier
    Pines, Pedro
    Blanco, Benito
    Gonzalez, Javier
    Lopez, Jose
    Herranz, Sandra
    Roa, Carlos
    Gomez-Romero, Francisco Javier
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (02): : 116 - 122
  • [49] Short-term and long-term impact of continuous subcutaneous insulin infusion therapy on HbA1c changes in Type 1 diabetes
    Josipovic, M. B.
    Evans, M. L.
    Hartnell, S.
    Davenport, K. H.
    Gurnell, E. M.
    DIABETIC MEDICINE, 2019, 36 : 147 - 147
  • [50] Loss of glycemic control over time after infusion line change in patients with type 1 diabetes treated with continuous subcutaneous insulin infusions.
    Thethi, T. K.
    Outland, J.
    Malik, T.
    Fonseca, V. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S296 - S296
12345